— Know what they know.
Not Investment Advice

BBBT OTC

Black Bird Biotech, Inc.
1W: +0.0% 1M: +0.0% 3M: +9900.0% YTD: +0.0% 1Y: +0.0% 3Y: -50.0% 5Y: -99.6%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 46 · $98405 mcap · 983M float · 0.188% daily turnover · Short 9% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.1M
52W Range0.0001-0.0001
Volume2,000,000
Avg Volume1,845,012
Beta1.95
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEONelson Grist
Employees4
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2009-11-11
11961 Hilltop Road
Argyle, TX 76226
US
833 223 4202
About Black Bird Biotech, Inc.

Black Bird Biotech Inc. operates within the biotechnology sector, offering a diverse array of products. A key offering is MiteXstream, a unique plant-derived biopesticide manufactured and distributed by the company, specifically formulated to eradicate spider mites. The company further diversifies its portfolio with a range of consumer goods sold under its Grizzly Creek Naturals brand. These include CBD oils, gummies, and pet treats, as well as CBD-infused personal care items and both gel and spray hand sanitizer products. Beyond these offerings, Black Bird Biotech also engages in the cultivation of industrial hemp, participating in the Montana Hemp pilot program. The entity, headquartered in Flower Mound, Texas, underwent a name change in June 2021, transitioning from its former identity as Digital Development Partners, Inc. to its current Black Bird Biotech, Inc. designation.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
Collins Jeffrey A 0 — 2009-01-15

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms